SOURCE-LINKED INTELLIGENCE
Integrated multi-angle research and training network to eradicate leukemia minimal residual disease
ress effective treatments to the clinic. The researchers within MIRACLE will be trained to obtain a unique combination of skills in innovative high-tech technologies, advanced data analysis tools and artificial intelligence, organ-on-chip MRD models, and drug and immunotherapy testing, and will come with innovative ideas to advance future leukemia treatment by integration of several disciplines and data sources. Leukemia, Minimal Residual Disease, Multi-omics, Immunotherapy, Organ-on-Chip
Read original source ↗ Open in workspace
- recordType
- award
- status
- SIGNED
- region
- EU
- value
- 2637950.4
- unit
- EUR
Evidence & attribution
European Commission, CORDIS Horizon Europe project dataset. Metadata adapted.
License: CORDIS reuse policy
First collected: 2026-09-20T03:21:21.440Z. This is not the publication date.